Literature DB >> 9442495

Massive reduction in methicillin resistance by transposon inactivation of the normal PBP2 in a methicillin-resistant strain of Staphylococcus aureus.

M G Pinho1, A M Ludovice, S Wu, H De Lencastre.   

Abstract

Screening of a large transposon library constructed in the background of a highly and homogeneously methicillin-resistant Staphylococcus aureus (MRSA) strain (methicillin MIC 1,600 micrograms/ml) for Tn551 mutants with reduced resistance, identified mutant RUSA130 with a methicillin MIC of 12 micrograms/ml. Cloning in E. coli followed by sequencing located the Tn551 insert omega 703 near the C-terminal of the PBP2 gene. Penicillin-binding assays with mutant RUSA130 showed the presence of normal amounts of penicillin-binding protein 2A (PBP2A) but the absence of PBP2. These observations suggest that the mecA gene product PBP2A is not the sole catalyst of peptidoglycan synthesis in MRSA growing in the presence of beta-lactam antibiotics, since an intact PBP2 is also essential for the optimal expression of methicillin resistance in MRSA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9442495     DOI: 10.1089/mdr.1997.3.409

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  17 in total

1.  Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.

Authors:  Susan Boyle-Vavra; Shaohui Yin; Mamatha Challapalli; Robert S Daum
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  A PBP 2 mutant devoid of the transpeptidase domain abolishes spermine-β-lactam synergy in Staphylococcus aureus Mu50.

Authors:  Xiangyu Yao; Chung-Dar Lu
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Transcriptional analysis of the Staphylococcus aureus penicillin binding protein 2 gene.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

5.  Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

6.  Penicillin-binding protein 1 of Staphylococcus aureus is essential for growth.

Authors:  A Wada; H Watanabe
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  Penicillin-binding protein 2 is essential for expression of high-level vancomycin resistance and cell wall synthesis in vancomycin-resistant Staphylococcus aureus carrying the enterococcal vanA gene complex.

Authors:  Anatoly Severin; Shang Wei Wu; Keiko Tabei; Alexander Tomasz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

9.  Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.

Authors:  Fred Goldstein; Jiri Perutka; Arabela Cuirolo; Konrad Plata; Diego Faccone; Joanne Morris; Aude Sournia; Marie Dominique Kitzis; Aicha Ly; Gordon Archer; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

10.  Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.

Authors:  Marilyn Chung; Aude Antignac; Choonkeun Kim; Alexander Tomasz
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.